Home/TRIMT/Dr. Dirk Freitag-Stechl, MBA
DD

Dr. Dirk Freitag-Stechl, MBA

Managing Partner

TRIMT

Therapeutic Areas

TRIMT Pipeline

DrugIndicationPhase
Trivehexinαvβ6 Integrin-positive CancersPreclinical
Therahexinαvβ6 Integrin-positive CancersPreclinical
Technehexinαvβ6 Integrin-positive CancersPreclinical
Triveoctinαvβ8 Integrin-positive CancersPreclinical
LPDL1PD-L1 positive CancersPreclinical
Undisclosed αvβ6 Integrin Dxαvβ6 Integrin-positive CancersDiscovery